Holle, Julia U <br/><br/>
Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations.  [electronic resource] 

 -  Annals of the rheumatic diseases  Mar 2012 
 - 327-33 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/ard.2011.153601  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Biomarkers--blood<br/>Blood Sedimentation<br/>C-Reactive Protein--metabolism<br/>Drug Administration Schedule<br/>Drug Evaluation<br/>Drug Therapy, Combination<br/>Female<br/>Granulomatosis with Polyangiitis--diagnosis<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Retrospective Studies<br/>Rituximab<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Young Adult